Barclays PLC Acquires 15,034 Shares of Cibus, Inc. (NASDAQ:CBUS)

Barclays PLC boosted its holdings in Cibus, Inc. (NASDAQ:CBUS) by 287.2% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,269 shares of the company’s stock after acquiring an additional 15,034 shares during the quarter. Barclays PLC owned 0.08% of Cibus worth $66,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in CBUS. FMR LLC grew its holdings in shares of Cibus by 16.9% during the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock worth $12,757,000 after purchasing an additional 566,328 shares in the last quarter. Armistice Capital LLC purchased a new position in Cibus in the 2nd quarter worth approximately $5,083,000. Wellington Management Group LLP bought a new position in shares of Cibus in the 3rd quarter worth $111,000. Charles Schwab Investment Management Inc. raised its position in shares of Cibus by 14.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock valued at $161,000 after buying an additional 6,276 shares in the last quarter. Finally, Rhumbline Advisers bought a new stake in shares of Cibus during the 2nd quarter worth $221,000. 33.81% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Canaccord Genuity Group reduced their target price on Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Wednesday. HC Wainwright reissued a “buy” rating and set a $25.00 price objective on shares of Cibus in a report on Monday, November 11th.

Cibus Stock Down 8.0 %

NASDAQ CBUS opened at $2.42 on Friday. The firm has a market cap of $64.03 million, a price-to-earnings ratio of -0.11 and a beta of 1.85. The company has a 50-day simple moving average of $3.37 and a two-hundred day simple moving average of $5.07. Cibus, Inc. has a 12-month low of $2.16 and a 12-month high of $23.18.

Cibus (NASDAQ:CBUS) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of ($0.89) by $0.95. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. The business had revenue of $1.67 million for the quarter, compared to analysts’ expectations of $0.47 million. During the same period in the previous year, the firm earned ($1.59) EPS. Equities analysts expect that Cibus, Inc. will post -2.96 earnings per share for the current fiscal year.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.